GAD and IA-2 autoantibody detection in type 1 diabetic patient saliva

Clinical Immunology

Volumn 131, Issue 2, 2009, Pages 271-276

  Tiberti, Claudio ^a   Shashaj, Blegina ^a   Verrienti, Antonella ^a   Vecci, Elio Giancarlo ^a   Lucantoni, Federica ^a   Masotti, Donata ^a   Morano, Susanna ^a   Sulli, Nicoletta ^a   Dotta, Francesco ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

GAD autoantibodies; Human saliva; IA 2 autoantibodies; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; METHIONINE; PROTEIN TYROSINE PHOSPHATASE; SULFUR 35;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SALIVA ANALYSIS; SERUM;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; REFERENCE STANDARDS; REGRESSION ANALYSIS; SALIVA; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 63749130894     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.12.002     Document Type: Article

References (18)

1. Atkinson M.A., and Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358 (2001) 221-229
2. Bingley B.J., Bonifacio E., Williams A.J.K., Genovese S., Bottazzo G.F., and Gale E.A.M. Prediction of IDDM in the general population: strategies based on combination of autoantibody markers. Diabetes 46 (1997) 1701-1710
3. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., and Eisenbarth G.S. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 autoantibodies. Diabetes 45 (1996) 926-933
4. Winter W.E., Harris N., and Shatz D. Immunological markers in the diagnosis and prediction of autoimmune type 1a diabetes. Clin. Diabetes 20 (2002) 183-191
5. Markopoulos A.K., Belazi M.A., and Drakoulakos D. Glutamic acid decarboxylase autoantibodies in saliva of children with type 1 diabetes. Diabetes Res. Clin. Pract. 38 (1997) 169-172
6. Todd A.L., Ng W.Y., Lee Y.S., Loke K.Y., and Thai A.C. Evidence of autoantibodies to glutamic acid decarboxylase in oral fluid of type 1 diabetic patients. Diabetes Res. Clin. Pract. 57 (2002) 171-177
7. Bingley P.J., Bonifacio E., Mueller P., and Participating Laboratories. Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 52 (2003) 1128-1136
8. Torn C., Mueller P.W., Schlosser M., Bonifacio E., and Bingley P.J. Diabetes Antibody Standardization Program: evaluation for assays for autoantibodies to glutamic acid decarboxylase and islet antigen 2. Diabetologia 51 (2008) 846-852
9. Bonamico M., Ferri M., Nenna R., Verrienti A., Di Mario U., and Tiberti C. Tissue transglutaminase autoantibody detection in human saliva: a powerful method for celiac disease screening. J. Pediatr. 144 (2004) 632-636
10. Grubin E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., Karlsen A.E., Boel E., Michelsen B., and Lernmark Å. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37 (1994) 344-350
11. Tiberti C., Verrienti A., Fiore B., Yu L., Eisenbarth G.S., Dotta F., and Di Mario U. IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes. Clin. Immunol. 115 (2005) 260-267
12. Brandtzaeg P. Salivary immunoglobulins. In: Tenuovo (Ed). Clinical Chemistry and Microbiology (1989), CRC Press Inc II 1-54
13. Brandtzaeg P. Two types of IgA immunocytes in man. Nat. New Biol. 243 (1973) 142-143
14. Schmidli R.S., Colman P., Bonifacio E., Bottazzo G.F., and Harrison L.C. High level of concordance between assays for glutamic acid decarboxylase antibodies: the first international glutamic acid decarboxylase antibody workshop. Diabetes 43 (1994) 55-66
15. Schmidli R.S., Colman P., Bonifacio E., and participating laboratories. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies, Second International GADAb Workshop. Diabetes 44 (1995) 636-640
16. Lamej P.J., Darwazeh A.M., and Frier B.M. Oral disorders associated with diabetes mellitus. Diabet. Med. 9 (1992) 410-416
17. Moore P.A., Guggenheimer J., Etzel K.R., Weyant R.J., and Orchard T. Type1 diabetes mellitus, xerostomia, and salivary flow rates. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endo. 92 (2001) 281-291
18. Bonamico M., Nenna R., Luparia R.P., Perricone C., Montuori M., Lucantoni F., Castronuovo A., Mura S., Turchetti A., Strappini P., and Tiberti C. Radioimmunological detection of anti-transglutaminase autoantibodies in human saliva: a useful test to monitor celiac disease follow-up, To explain these discordant findings it is possible to formulate various hypothesis. Aliment. Pharmacol. Ther. (2008) Apr 21 [Electronic publication ahead of print]